About
At Veracyte, we offer exciting career opportunities for those interested in joining a pioneering team that is committed to transforming cancer care for patients across the globe. Working at Veracyte enables our employees to not only make a meaningful impact on the lives of patients, but to also learn and grow within a purpose driven environment. This is what we call the Veracyte way – it’s about how we work together, guided by our values, to give clinicians the insights they need to help pati...
Updates & Highlights
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Veracyte?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentVeracyte Q2 Earnings Call Highlights
Veracyte Q2 Earnings Call Highlights
Yahoo Finance · 1 day ago
Veracyte (VCYT) Stock Sinks As Profit Strength Meets Reimbursement Doubt
Veracyte (VCYT) Stock Sinks As Profit Strength Meets Reimbursement Doubt
simplywall.st · 1 day ago
A Look at Veracyte Inc (VCYT) After 22.6% Decline -- GF Value $3
A Look at Veracyte Inc (VCYT) After 22.6% Decline -- GF Value $3
GuruFocus · 1 day ago
VERACYTE, INC. 2026: Revenue $150.32M, EPS $0.31— 10-Q Summary
VERACYTE, INC. 2026: Revenue $150.32M, EPS $0.31— 10-Q Summary
TradingView · 1 day ago
Veracyte, Inc. Stock 12‑Month Price Target Raised to $60.18, Implies 1% Upside
Veracyte, Inc. Stock 12‑Month Price Target Raised to $60.18, Implies 1% Upside
TradingView · 1 day ago
Veracyte, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:VCYT) 2026-07-31
Veracyte, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:VCYT) 2026-07-31
Seeking Alpha · 2 days ago
Is Veracyte (VCYT) Fully Valued After Raising 2026 Revenue Guidance?
Is Veracyte (VCYT) Fully Valued After Raising 2026 Revenue Guidance?
Yahoo Finance · 2 days ago
Needham raises Veracyte stock price target to $69 on strong Q2 beat
Needham raises Veracyte stock price target to $69 on strong Q2 beat
Investing.com · 2 days ago
Veracyte Inc (VCYT) (Q2 2026) Earnings Call Highlights: Record R
Veracyte Inc (VCYT) (Q2 2026) Earnings Call Highlights: Record R
GuruFocus · 2 days ago
Is Veracyte Inc (VCYT) Still a Strong Investment After Q2 Earnin
Is Veracyte Inc (VCYT) Still a Strong Investment After Q2 Earnin
GuruFocus · 2 days ago
Veracyte Q2 2026 slides: growth accelerates, new launches emerge
Veracyte Q2 2026 slides: growth accelerates, new launches emerge
Investing.com · 2 days ago
Veracyte (VCYT) Q2 Earnings and Revenues Surpass Estimates
Veracyte (VCYT) Q2 Earnings and Revenues Surpass Estimates
Yahoo Finance · 2 days ago
Earnings call transcript: Veracyte beats Q2 2026 estimates but shares fall after hours
Earnings call transcript: Veracyte beats Q2 2026 estimates but shares fall after hours
Investing.com · 2 days ago
Veracyte Releases Q2 2026 Financial Results
Veracyte Releases Q2 2026 Financial Results
AlphaStreet · 2 days ago
Veracyte Inc earnings beat by $0.11, revenue topped estimates
Veracyte Inc earnings beat by $0.11, revenue topped estimates
Investing.com · 3 days ago
Veracyte: Q2 Earnings Snapshot
Veracyte: Q2 Earnings Snapshot
kens5.com · 3 days ago
Veracyte (VCYT) Q2 2026 Earnings
Veracyte (VCYT) Q2 2026 Earnings
247wallst.com · 3 days ago
Veracyte Q2 revenue rises 15% to $150.3 million
Veracyte Q2 revenue rises 15% to $150.3 million
Quiver Quantitative · 3 days ago
Earnings Flash (VCYT) Veracyte, Inc. Posts Q2 Adjusted EPS $0.54 per Share, Vs. FactSet Est of $0.43
Earnings Flash (VCYT) Veracyte, Inc. Posts Q2 Adjusted EPS $0.54 per Share, Vs. FactSet Est of $0.43
Moomoo · 3 days ago
BRIEF-Veracyte Q2 Revenue USD 150.3 Million Vs. IBES Estimate USD 144.6 Million
BRIEF-Veracyte Q2 Revenue USD 150.3 Million Vs. IBES Estimate USD 144.6 Million
TradingView · 3 days ago